Hadassah performs first-ever alpha radiation treatment for recurring brain tumors

Hadassah Medical Center in Jerusalem has performed the world's first alpha radiation treatment for recurrent aggressive brain tumors using Alpha DaRT technology. A 77-year-old man with recurrent glioblastoma was the first patient to receive this innovative treatment, which delivers highly concentrated alpha particles directly to the tumor with minimal damage to surrounding tissue. The procedure, led by Professor Yigal Shoshan, integrates with existing neurosurgical navigation systems for precise insertion of radiation sources. This development offers a new direction for a disease with extremely limited treatment options, with preclinical studies also suggesting a potential immune response. Professor Aron Popovtzer noted that glioblastoma almost always recurs despite conventional treatments, making this a crucial step. Uzi Sofer, CEO of Alpha Tau, an Israeli company, highlighted the significance of this milestone, emphasizing its scientific, business, and Zionist importance.